AMA Releases Updates to Category I, III CPT Codes

 The American Medical Association has released updates to several Category I vaccine CPT codes.

The FDA pending indicator has been removed from CPT 90670, and CPT 90644 was approved after the AMA’s October editorial meeting, according to the update.

The following Category I codes were revised in the update:

  • CPT 90663 (Influenza virus vaccine, pandemic formulation, H1N1)
  • CPT 90650 (Human Papilloma virus vaccine, types 16, 18, bivalent, 3 dose schedule, for intramuscular use)
  • CPT 90662 (Influenza virus vaccine, split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use)

The following Category I codes are new codes, according to the update:

  • CPT 90470 (H1N1 immunization administration (intramuscular, intranasal), including counseling when performed)
  • CPT 90664 (Influenza virus vaccine, pandemic formulation, live, for intranasal use)
  • CPT 90666 (Influenza virus vaccine, pandemic formulation, split virus, preservative free, for intramuscular use)
  • CPT 90667 (Influenza virus vaccine, pandemic formulation, split virus, adjuvanted, for intramuscular use)
  • CPT 90668 (Influenza virus vaccine, pandemic formulation, split virus, for intramuscular use)